- Kardiovaskulární nežádoucí účinky anti-VEGF terapie v onkologii2021 | Third Faculty of Medicine
- Efficacy of anti-VEGF therapy (aflibercept) in advanced colorectal cancer2019 | Publication without faculty affiliation
- Brolucizumab - A New Player In The Field Of Anti-VEGF Therapy Of Neovascular Age-Related Macular Degeneration. A Review2022 | First Faculty of Medicine
- Infectious Complications of Intravitreal AntiVEGF Therapy of the Wet Form of Age-Related Macular Degeneration2013 | First Faculty of Medicine
- Effect of baseline central retinal thickness on the results of treatment of diabetic macular edema with aflibercept: real-life evidence in the Czech republic2022 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- One-year follow-up outcomes of the treatment of wet age-related macular degeneration with aflibercept2018 | Third Faculty of Medicine